News
The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.
8h
The Journal News on MSNEye drop manufacturer AvKARE issues recall on certain products. What to knowFive different eye drop products that were sold between May 2023 and April 2025 were identified in a recall from manufacturer ...
Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...
21hon MSN
Transportation Secretary Sean Duffy says he plans to reduce the number of flights in and out of Newark’s airport for the ...
The White House unveiled a sweeping plan to try to lower prescription drug prices, one that calls for a "most-favored nation" ...
In this week's Health Care Inc. newsletter, UnitedHealth’s financial miscues, an $800 million revenue cycle bonanza, and much ...
President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...
As soon as it becomes possible to consider using eye drops, everyone who regularly uses them should start doing a ...
Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the crown jewel of US biomedical research with ideology and cronyism.
The completion of the FDA filing prompts a $10 million milestone payment to Capricor from Japan's Nippon Shinyaku, which licensed US rights to deramiocel in 2022 and added in European rights in a ...
A magnitude 5.7 earthquake rattled Tibet early Monday at a shallow depth of 10km, as reported by the National Center for Seismology. This follows a smaller 3.7 magnitude quake just days prior in ...
MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a lawsuit from Novartis claiming patent infringement and seeking a preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results